We’re a programmable clinical-stage cell therapy company focused on the realization of solid tumor cell therapies. Our purpose is very clear: defeat cancer.
Today at the Evolution Summit, ArsenalBio’s Farah Anwar will share insights on CAR-T cell therapy and its potential to redefine the future of personalized cancer treatment.
This Wednesday, ArsenalBio’s Farah Anwar will join a panel of clinical trial experts to share strategies for balancing scientific rigor, operational efficiency, and the patient experience.
We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: bit.ly/3JHY0wb